SCHEMBL7862810

SCHEMBL7862810

CCOCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(OCC(F)(F)C(F)(F)C(F)(F)F)cc2)cn1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.39
EPHX2 P34913 7/20 0.38
EGFR P00533 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
BCL2L1 Q07817 2/20 0.34
MCL1 Q07820 2/20 0.34
EGLN1 Q9GZT9 1/20 0.34
KCNH2 Q12809 1/20 0.34
SCN9A Q15858 1/20 0.34
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869926 0.88 P4HTM (0.47) P4HTMEGFRSMN1; SMN2RAB9ANPC1
SCHEMBL7867824 0.88 P4HTM (0.44) P4HTMEPHX2EGFRRAB9AKCNH2
SCHEMBL9574743 0.87 SMN1; SMN2 (0.40) SMN1; SMN2RAB9AALDH1A1
SCHEMBL7867703 0.84 EGFR (0.45) P4HTMEPHX2EGFRSMN1; SMN2RAB9A
SCHEMBL7870559 0.84 EGFR (0.41) P4HTMEPHX2EGFRBCL2L1MCL1
SCHEMBL7870444 0.84 P4HTM (0.46) P4HTMEPHX2EGFRSMN1; SMN2RAB9A
SCHEMBL7871544 0.83 MCL1 (0.49) P4HTMBCL2L1MCL1
SCHEMBL7862692 0.83 EGFR (0.43) P4HTMEPHX2EGFRSMN1; SMN2RAB9A
SCHEMBL9574842 0.82 EGFR (0.43) P4HTMEPHX2EGFRSMN1; SMN2RAB9A
SCHEMBL7869460 0.82 EGFR (0.43) P4HTMEPHX2EGFRSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed